165 related articles for article (PubMed ID: 33369084)
1. Risk factors for cancer-associated myositis: A large-scale multicenter cohort study.
Li Y; Jia X; Sun X; Shi L; Lin F; Gan Y; Zhang X; Gao X; Miao M; Hong D; Li Y; He J
Int J Rheum Dis; 2021 Feb; 24(2):268-273. PubMed ID: 33369084
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of cancer-associated myositis complicated by interstitial lung disease: a large-scale multicentre cohort study.
Kaneko Y; Nunokawa T; Taniguchi Y; Yamaguchi Y; Gono T; Masui K; Kawakami A; Kawaguchi Y; Sato S; Kuwana M;
Rheumatology (Oxford); 2020 Jan; 59(1):112-119. PubMed ID: 31382295
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for myositis-associated interstitial lung disease.
Fujisawa T; Hozumi H; Kono M; Enomoto N; Hashimoto D; Nakamura Y; Inui N; Yokomura K; Koshimizu N; Toyoshima M; Shirai T; Yasuda K; Hayakawa H; Suda T
PLoS One; 2014; 9(6):e98824. PubMed ID: 24905449
[TBL] [Abstract][Full Text] [Related]
5. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
Ikeda S; Arita M; Misaki K; Mishima S; Takaiwa T; Nishiyama A; Ito A; Furuta K; Yokoyama T; Tokioka F; Noyama M; Yoshioka H; Ishida T
Springerplus; 2015; 4():240. PubMed ID: 26101728
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T
Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
[TBL] [Abstract][Full Text] [Related]
7. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
[TBL] [Abstract][Full Text] [Related]
8. [The clinical significance of myositis-specific antibodies in polymyositis/dermatomyositis associated interstitial lung diseases].
Xie MM; Yan X; Li H; Ding JJ; Gui XH; Liu Y; Wang YS; Chen ZY; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Aug; 41(8):616-621. PubMed ID: 30138971
[No Abstract] [Full Text] [Related]
9. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
[TBL] [Abstract][Full Text] [Related]
11. Analysis of myositis autoantibodies in Chinese patients with cancer-associated myositis.
Li L; Liu C; Wang Q; Wu C; Zhang Y; Cheng L; Wen X; Zeng X; Zhang F; Li Y
J Clin Lab Anal; 2020 Aug; 34(8):e23307. PubMed ID: 32222002
[TBL] [Abstract][Full Text] [Related]
12. Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort.
András C; Bodoki L; Nagy-Vincze M; Griger Z; Csiki E; Dankó K
Pathol Oncol Res; 2020 Jul; 26(3):1749-1755. PubMed ID: 31646426
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of HRCT in myositis-associated interstitial lung disease.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Aihara K; Ikezoe K; Watanabe K; Taguchi Y; Hatta K; Oga T; Chin K; Nagai S; Mimori T; Mishima M
Respir Med; 2013 May; 107(5):745-52. PubMed ID: 23485097
[TBL] [Abstract][Full Text] [Related]
14. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
Wang PZ; Guan JL; Han XH
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
[TBL] [Abstract][Full Text] [Related]
15. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
[No Abstract] [Full Text] [Related]
17. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
[TBL] [Abstract][Full Text] [Related]
18. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
Bai Z; Shen G; Dong L
Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease.
Johnson C; Pinal-Fernandez I; Parikh R; Paik J; Albayda J; Mammen AL; Christopher-Stine L; Danoff S
Lung; 2016 Oct; 194(5):733-7. PubMed ID: 27166633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
